ENDOTOXIN AND TUMOUR NECROSIS FACTOR DO NOT CAUSE MORTALITY FROM CAECAL LIGATION AND PUNCTURE Kelly M. McMasters,
James C. Peyton, Dimitri William G. Cheadle
J. Hadjiminas,
Macrophage tumour necrosis factor-alpha (TNF-(w) production is thought to represent an important pathogenic mechanism by which Gram-negative sepsis is mediated. We compared the effects of caecal ligation and puncture (CLP) on endotoxin-sensitive (C3H/HeSnJ) and endotoxin-resistant (C3H/HeJ) mice. Mortality after CLP for C3H/HeSnJ mice compared with C3H/HeJ mice was not significantly different (32% and 55%, respectively). When survivors were injected with lipopolysaccharide intraperitoneally on the 7th day after CLP, the mortality rate was 82% for C3H/HeSnJ mice versus 0% for C3H/HeJ mice (P < 0.0001). Serum endotoxin levels at 24 h after CLP were only slightly elevated. Serum TNF levels and peritoneal macrophage TNF production were undetectable in C3H/HeJ mice and were only slightly elevated in C3H/HeSnJ mice by 24 h after CLP. Peritoneal macrophage mRNA levels for TNF-a, IL-l/3, and I-Ao displayed a similar pattern in the two strains of mice, with a 2to 3-fold increase in TNF-(x and IL-lp mRNA levels by 24 h and a sharp decrease in I-Ao mRNA by 24 h. The cause of mortality in mice that undergo CLP cannot be attributed to overwhelming endotoxemia and/or TNF production.
Intra-abdominal infection often leads to multiple organ failure and death despite aggressive surgical intervention, appropriate antibiotic therapy, and intensive care unit monitoring. A fatal outcome is usually the result of the immune system ineffectively containing or eradicating the infection. Two related but distinct types of immune system dysfunction have been proposed to cause this process. They are over expression or adverse regulation of proinflammatory mediators (locally or systemically), resulting in shock and tissue damage,’ and the other is decreased ability of the immune system to mount an antimicrobial attack.2 Tumour necrosis factor (TNF) and interleukin 1 (IL-l) have been implicated as mediators of the toxic
From the Department of Surgery, University of Louisville School of Medicine, and the Veterans Administration Medical Center, Louisville, Kentucky, USA. Presented at the 13th Annual Meeting for the Surgical Infection Society, Baltimore, Maryland, April 28 to May 1, 1993. Correspondence to: William G. Cheadle, MD, Department of Surgery, University of Louisville, Louisville, KY 40292, USA. Received 1 October 1993; revised and accepted for publication 15 March 1994 0 1994 Academic Press Limited 1043-4666/94/050530+07 $08.00/O KEY WORDS: Class II MHC antigens/endotoxin/interleukin sepsis/tumour necrosis factor 530
l/
effects of Gram-negative sepsis and endotoxemia. This implication has been supported by the fact that (1) endotoxemia or Gram-negative bacteremia is associated with an increase in serum TNF and IL-l levels,37 (2) administration of TNF or IL-l mimics many of the deleterious effects of endotoxiqs” and (3) therapy directed at neutralizing the effects of TNF or IL-l protects animals against the lethal effects of endotoxin. 12-15 Many studies of the effects of sepsis have relied on animal models that employ the injection of endotoxin or Gram-negative bacteria. Caecal ligation and puncture (CLP) is thought to be a better model because it simulates a common surgical problem of perforated, necrotic bowel and more closely mimics the physiologic changes found in human sepsis.16’17 Even though these are all models of sepsis, there are marked differences between models of endotoxemia or Gram-negative bacteremia and models of CLP in terms of cytokine expression and response to anticytokine therapy. The data reported herein examine the mechanism by which CLP causes immune system dysfunction and mortality. In particular, we investigated how the reduced ability of the C3WHeJ mice to produce TNF affects: (1) mortality; (2) expression of IL-ll3 mRNA, a proinflammatory mediator with a central role in this model of sepsis;” and (3) suppression of I-Aa (murine major histocompatibility CYTOKINE,
Vol. 6, No. 5 (September), 1994: pp 530-536
TNF and LPS in intra-abdominal
class II antigen) antigen expression, which has been shown to correlate with outcome and survival in infected severely injured mice.i’
infection / 531
organisms were also recovered from all blood cuitures. The anaerobic organisms that were identified included Bacteroides vulgatus and Clostridium species; whereas aerobic organisms included E. coli and Proteus mirabilis. No positive blood cultures were obtained from normal mice or sham-operated mice.
RESULTS
Mortality
Endotoxin Levels
Mortality from CLP is shown in Table 1. All deaths occurred within 3 days after CLP, except for one that occurred in a C3WHeSnJ mouse on the 4th day after CLP.
Serum endotoxin levels after CLP are shown in Fig. 1. Endotoxin levels were slightly higher in both mouse strains at 24 h after CLP compared with the sham-operated controls, but these differences were not statistically significant (n = 3).
TABLE 1. Mortality after CLP and LPS intraperitoneal injection in C3H/HeSnJ and C3HIHeJ mice. Strain of mice
Caecal ligation and puncture
C3WHeSnJ C3WHeJ
11/34 (32%)t 18/33 (55%)t
* One milligram of LPS was injected 7th day after CLP. i No significant difference. $ P < 0.0001 Fisher’s exact test.
intraperitoneally
Lipopolysaccharide injection (1 mg)”
9/11 (82%)$ O/16 (O%)$ in the survivors
on the
d
Caecal and Blood Cultures Caecal cultures were taken from C3II/HeSnJ, C3H/HeJ, and Swiss Webster mice to examine potential differences in intestinal flora. Caecal cultures grew both aerobic (Escherichia coli, Proteus species, Pseudomonas species) and anaerobic (Bacteroides vulgatus, Clostridium species) organisms, but no differences in the caecal flora was evident among the three strains of mice. In all three strains of mice, the predominant organisms cultured from blood during the early stages of infection were anaerobes (Table 2). By 24 h, aerobic
T
1 3
Pre
Time
post
i
24
CLP (h)
Figure 1. Serum endotoxin levels after CLP in C3H/HeSnJ mice (0) and C3WHeJ mice (a). Values are expressed as +SEM.
TNF Production TABLE 2. Positive blood cultures after CLP. Hours after CLP 1 hour
3 hours 24 hours
Type of Organism
Anaerobic Aerobic Anaerobic Aerobic Anaerobic Aerobic
C3WHeSnJ
C3WHe.J
Swiss Webster
o/3 o/3 313 o/3 u3
o/3 o/3 313 o/3 213
o/4 o/4 414 l/4 314
213
o/3
314
Serum TNF levels after CLP were undetectable in normal endotoxin-resistant (C3H/HeJ) mice, and at 1, 3 and 24 h after CLP. TNF was not detected in normal endotoxin-sensitive (C3HHeSnJ) mice, or at 1 h after CLP. However, at 3 h after CLP, 2 of 6 mice (C3H/ HeSnJ) had detectable serum TNF (250, 300 pg/ml), and at 24 h, 4 of 6 animals (C3WHeSnJ) had measurable levels of TNF (200, 320, 480, 550 pg/ml). TNF might have been present in the serum of the rest of the
532 I McMasters
CYTOKINE,
et al.
Vol. 6, No. 5 (September 1994: 530-536)
TABLE 3. Relative mRNA levels determined by Densitometric scanning.* 6 ht
Normal C3WHeSnJ
TNF-(w IL-q3 I-Aa * Values expressed 7 Time after CLP.
100 100 100 as percent
C3WHeJ
C3WHeJ
C3WHeSnJ
92 147 12
51 135 144 of C3WHeSnJ
24 ht C3WHeSnJ
128 266 70
C3WHeJ
300 264 4
263 191 8
controls.
mice but at concentrations below the detection limit of the ELISA. Peritoneal macrophage production of TNF was measured by harvesting peritoneal macrophages 24 h after CLP and culturing for 2 h in the absence or presence of LPS (1 kg/ml). TNF was not detected in cultures of C3WHeJ peritoneal macrophages with or without LPS stimulation using either the bioassay or ELISA methods. Using the bioassay method, mean TNF levels in peritoneal macrophages from C3W HeSnJ mice were lower without LPS compared with levels in mice with LPS (177 + 27 U/ml versus 197 f 19 U/ml). Using the ELISA method, TNF production in peritoneal macrophages from C3WHeSnJ mice was detected in 1 of 2 cultures (30 pg/ml) without LPS, and 2 of 2 cultures with LPS (50 and 200 pg/ml). Culture supernatant was assayed undiluted.
MessengerRNA Levels Peritoneal macrophage mRNA levels for TNF-o, IL-l/3, and I-Ao displayed a similar pattern in both strains of mice, with a 2- to 3-fold increase in TNF-a and IL-Q mRNA levels by 24 h and a sharp decrease in I-Ao levels by 24 h (Table 3). A representative sample of the Northern blot of IL-lp mRNA is shown in Fig. 2. According to our blots, normal peritoneal macrophages cultured for 1 h in endotoxin-free media constitutively expressed low levels of TNF and IL-l mRNA. Constitutive expression of TNF mRNA has been previously shown in normal tissues without any cell isolation or culture.20
DISCUSSION The terms intra-abdominal sepsis and Gramnegative sepsis often are used interchangeably. While intra-abdominal infection in patients may lead to Gram-negative bacteremia, most cases of secondary peritonitis are polymicrobial infections, and blood cultures usually return with no growth of any organ-
1
2
3
4
5
6
L
I
I
Figure 2. Northern blot of peritoneal macrophage IL-lp mRNA levels after CLP. Ten micrograms of total mRNA were analysed in each lane of the blot. Lane 1: normal C3WHeSnJ strain; Lane 2: normal C3W HeJ strain; Lane 3: C3WHeSnJ strain, 6 h after CLP; Lane 4: C3H/ HeJ strain, 6 h after CLP; Lane 5: C3WHeSnJ strain, 24 h after CLP: and Lane 6: C3WHeJ strain, 24 h after CLP.
isms.‘l Animal models of sepsis have been developed that utilize: (1) intravascular administration of bacterial endotoxin or Gram-negative bacteria, (2) intraperitoneal administration of bacteria (Gram-negative or polymicrobial), and (3) peritoneal contamination with the animal’s own intestinal flora, such as cLP.16,22 Intravascular injection of endotoxin or Gramnegative bacteria causes a profound increase in serum levels of TNF.3,4,7 Intraperitoneal injection of endotoxin appears to have similar effects as intravascular injection. 23 Administration of anti-TNF antibodies prevents mortality in these models, indicating an important role for TNF in mediating the lethal effects of endotoxemia or Gram-negative bacteremia. 12,I3 Interleukin 1 is also markedly elevated in these models.5-7 Administration of IL-l receptor antagonist (IL-lra) has been shown to reduce mortality from endotoxic shock without altering serum TNF levels. IL-lra is a naturally occurring protein that binds to
TNF and LPS in intra-abdominal
the IL-l receptor with equal affinity to IL-l3 and has no agonist activity.24 Bagby et al. 25 compared the effects of intravascular injection of endotoxin or Gram-negative bacteria with intraperitoneal injection of Gram-negative bacteria or a polymicrobial inoculum. They found that intravascular injection of endotoxin or E. coli (live or dead) produced a substantial transient increase in serum TNF levels, while the group receiving the intraperitoneal challenge with E. coli or a polymicrobial faecal inoculum had a lower serum TNF level. They also found that pretreatment with anti-TNF antibodies protected animals from the lethal effects of intravascular injection of endotoxin but was ineffective in preventing mortality from E. coli peritonitis. Serum TNF levels have been shown to be lower, or even undetectable, after CLP when compared with models of endotoxemia or Gram-negative bacteremia.23,25-29 Furthermore, administration of an anti-TNF monoclonal antibody prior to, or up to, 8 h after a sublethal CLP challenge was shown in these studies to result in the death of all animals within 3 days. The lethal effects of this antibody were negated by administration of exogenous TNF, suggesting that endogenously produced TNF is necessary for recovery from CLP.30 Other studies have confirmed that antiTNF antibodies do not prevent lethality from CLP.31,32 In contrast, the presence of IL-lra has been shown to protect rats from the lethal effects of CLP,” implicating IL-1 as an important mediator in this model of sepsis. This view is further supported by our results, as both endotoxin (LPS)-resistant and endotoxin (LPS)-sensitive mice showed similar upregulation of their IL-1 mRNA. C3WHeJ mice are thought to be resistant to the lethal effects of endotoxin because of a genetic defect, mapped to a single locus on chromosome 4 (LPSd) that renders these animals less able to produce TNF in response to endotoxin stimulation.3 Resistance of C3WHeJ mice to endotoxin is limited to certain preparations of LPS, specifically those lacking lipid A associated protein.33 There is evidence that C3H/HeJ mice produce TNF in response to some bacterial challenges.34 The relative resistance of the C3WHeJ mice to some (but not all) preparations of LPS does not necessarily make them unable to produce TNF in response to a polymicrobial challenge such as CLP. Our results show, however, that C3H/HeJ mice did not produce TNF after CLP but were still subjected to similar mortality. Our study confirms a report from Kisala et al. ,35 in which mortality from CLP did not differ between endotoxin-sensitive and endotoxinresistant mouse strains, but contradicts a report by Baker et al. ,36 who found that C3H/HeJ mice were resistant to mortality from CLP. In that study, however, the two strains of mice were obtained from
infection / 533
different breeders, which may have accounted for their findings. Macrophages from endotoxin-resistant C3WHeJ mice are also hyporesponsive to endotoxin stimulation in terms of IL-l production. Baker et al. ,37 however, have shown that splenic macrophages from endotoxin-resistant C3WHeJ mice express more IL-l after CLP than endotoxin-sensitive C3WHeN mice. This suggests that factors other than endotoxin may stimulate IL-l production after CLP and warrants further study. Tolerance to the effects of endotoxin can be induced by prior exposure to sublethal doses of endotoxin.38,39 Our results indicate that endotoxinsensitive mice did not become tolerant to the lethal effects of endotoxin by virtue of prior CLP, and that endotoxin-resistant mice retain their endotoxin resistance after CLP. We found that serum endotoxin levels showed a slight elevation at 24 h after CLP. Serum TNF levels and peritoneal macrophage TNF production were elevated in C3H/HeSnJ mice after CLP, but were undetectable in C3WHeJ mice. Ayala et al.26 demonstrated that serum endotoxin levels after CLP were approximately 20- to 30-fold higher than those reported herein and found that serum TNF levels in C3WHeJ mice were actually 25fold higher than in endotoxin-sensitive animals.27 Explanations for these discrepancies may be due to the differences in intestinal flora or assay techniques (bioassay versus ELISA). Recently, we demonstrated 2- to 3-fold increases in peritoneal macrophage TNF-ok and IL-ll3 mRNA levels, and a sharp decrease in I-ACY mRNA levels after CLP in Swiss Webster mice.40 In the present study, a similar pattern of mRNA expression was found in C3WHeSnJ and mice, except that the level of TNF-a mRNA in peritoneal macrophages from normal C3WHeJ mice was half that of normal C3Hi HeSnJ mice (Table 3), and C3WHeJ mice showed a less pronounced decrease at 6 h in I-Aa mRNA levels than C3WHeSnJ mice but similar suppression at 24 h. Suppression of major histocompatibility (MHC) class II antigen expression correlates with a reduced capacity for antigen presentation4i and may contribute to lethality from CLP. Suppression of MHC class II antigen expression in surgical patients correlates with the development of infection and clinical outcome.42,43 Restoration of MHC class II of infected mice to normal levels improves survivali However, in contrast to other experimental models where MHC class II suppression is due to TNF secretion,44 our results suggest that after CLP, the decline of I-Aa is not mediated by TNF. Our finding that the levels of TNF mRNA increase after CLP in C3WHeJ mice confirms reports from others that there is a defect in translation of TNF
534 I McMasters
CYTOKINE, Vol. 6, No. 5 (September1994:530-536)
et al.
mRNA in these mice.3 Increased TNF mRNA levels, however, do not imply intact transcription mechanisms because stabilization of the TNF and IL-1 mRNA molecules to the action of ribonucleases is an important mechanism of regulation of their levels.45 We conclude that even though the lethal effects of CLP are generally thought to be caused by overwhelming Gram-negative bacteremia and endotoxic shock, several observations contradict this belief. Our findings suggest that the lethal effects of CLP cannot be attributed simply to endotoxemia and the toxic effect of excessive TNF expression. We found that CLP caused a polymicrobial infection characterized by predominantly anaerobic bacteremia within the first 24 h. These results are comparable to the results of Hyde et a1.31 CLP resulted in only a slight increase in serum endotoxin levels compared with models of Gram-negative bacterial infection CLP did not cause the same dramatic increase in serum TNF levels as seen with the administration of an endotoxin or Gram-negative bacteria (LPS). Administration of anti-TNF antibodies decreases mortality in models of endotoxemia or Gram-negative bacteremia, but actually increases mortality from CLP. Endotoxinresistant C3H/HeJ mice are resistant to mortality induced by intraperitoneal injection of endotoxin or Gram-negative bacteria (presumably because of decreased ability to produce TNF) but not to CLP. The fact that IL-lra improves survival from both endotoxin injection and CLP suggests an important role for this cytokine in the pathophysiology of both models. The latter observation and or results converge to the conclusion that lethality from CLP is associated with an overexpression of IL-l, a suppression of MHC class II antigen expression, and is independent of the capacity to produce TNF.
MATERIALS AND METHODS
scribed by Baker et al.46 Specifically, the mice were anaesthetized with subcutaneous ketamine (80 mg/kg) and xylazine (16 mg/kg). Through a midline laparotomy incision, the caecum was ligated just below the ileocaecal junction with 3-O silk and was punctured once with an 18gauge needle. Using gentle pressure on the caecum, a small amount of faecal material was expressed to ensure the patency of the puncture holes. The abdominal incision was then closed with nylon suture. No fluid resuscitation was given after CLP.
Mortality Mortality was determined in C3WHeSnJ (n = 34) and C3WHeJ (n = 33) mice following CLP. Seven days after CLP, surviving C3WHeSnJ (n = 11) and C3H/HeJ (n = 16) mice were injected with 1 mg of endotoxin (LPS) intraperitoneally (E. coli serotype Olll:B4, phenol extracted [Sigma Chemical Co., St. Louis, MO]). This was done to determine if the CLP procedure released enough endotoxin in the endotoxin-sensitive mice to prime them. Priming is a known method by which a sublethal endotoxin dose is able to induce tolerance to a subsequent lethal endotoxin exposure. 38,3gThis would also determine if the normally endotoxin-resistant mice were made susceptible to endotoxin by CLP.
Caecal and Blood Cultures Caeca from C3WHeSnJ and C3WHeJ mice were excised and cultured to assesspossible differences in indigenous flora. Blood cultures were obtained from C3H/ HeSnJ, C3WHeJ and Swiss Webster mice at various intervals following no treatment (control), sham laparotomy (sham) or CLP. The blood was obtained by cardiocentesis following thoracotomy, with the abdominal cavity still closed to avoid contamination. Samples were incubated on MacConkey’s agar and tryptic soy agar with 5% sheep’s blood under strict anaerobic conditions for 48 to 72 h for determination of aerobic organisms. The clinical laboratory at the Veterans Administration Medical Center (Louisville, KY) was used for identification of bacteria.
Animals
Peritoneal
Adult male endotoxin-sensitive (C3H/HeSnJ), endotoxin-resistant (C3H/HeJ) (Jackson Laboratory, Bar Harbor, ME), and SwissWebster mice (Charles River Laboratories, Portage, MI), weighing between 25 g to 30 g, were studied. The mice were housed in an American Association for Accreditation of Laboratory Animal Care (AAALAC)-approved facility under the supervision of a veterinarian and were fed standard rodent chow and water ad libitum. All of the mice remained housed in our facility for at least 2 weeks before the experimentation to allow equilibration of intestinal flora. Studies were carried out in strict accordance with the National Institutes of Health guidelines for the treatment of laboratory animals.
Animals were killed by cervical dislocation to isolate peritoneal macrophage. Pooled groups of 5 to 10 C3W HeSnJ and C3WHeJ mice were used for each macrophage isolation. Macrophages were harvested by peritoneal lavage with ice-cold RPM1 1640 medium (GIBCO/BRL, Bethesda, MD). Resident peritoneal macrophages from normal animals were used as controls. After centrifugation at 200 x g, the cells were resuspended at a concentration of lo6 cells/ml in RPM1 1640 medium supplemented with penicillin (100 IU/ml), streptomycin (100 &ml), and glutamine (2 mM). Ten millilitres of the cell suspension was plated into loo-mm tissue culture plates (Falcon, Lincoln Park, NJ). The macrophages were then allowed to adhere for 1 h in a humidified CQ, (5%) incubator at 37°C. The plates were washed three times .with warm media to remove nonadherent cells. This protocol has resulted routinely in macrophage cultures con-
Caecal ligation
and puncture
Caecal ligation and puncture was performed as de-
Macrophage
Isolation
TNF and LPS in in&a-abdominal
taining >95% nonspecific esterase-positive cells. Extraction of total RNA was performed immediately after washing the cells. Media were stored frozen at -70°C for TNF assay.
TNF Assay TNF-a levels in serum samples were determined using an ELISA assay(FactorTest-mouse TNFa, Genzyme, Cambridge, MA), following 1~3dilution according to the protocol provided by the manufacturer. TNF levels in culture media were determined by the WEHI 164 subclone 13 cell line bioassay, as described by Eskandari et al.47 TNF levels in undiluted culture media were also measured by the ELISA method to ensure that immunoreactive TNF does not exist in a biologically inactive form in C3WHeJ mice.
Endotoxin Assay Endotoxin levels were determined in 1:4 dilutions of mouse serum using the limulus amebocyte assay (QCL1000, BioWhittaker, Walkersville, MD), according to the manufacturer’s protocol and as described by Ayala et a1.26
Total RNA Extraction and mRNA Analysis Extraction of total RNA from isolated macrophages and tissues was performed by the method of Chomczynski and Sacchi.48 Northern blot analysis was performed as described previously40,49 using 32P-labelled complementary DNA (cDNA) probes. The mouse TNF-(Y and IL-l@ cDNA probes were the gift of Dr Arjun Singh (Genentech, Inc., South San Francisco, CA). The I-Aa probe used was pRAAC, an 880 bp A-alphak cDNA, which was generously provided by Dr Jerold Woodward (Albert B. Chandler Medical Center, University of Kentucky, Lexington, KY). Equal loading and transfer of each mRNA sample was verified by ethidium bromide staining of the blots, according to the method of Mendelssohn and Coleman.” Northern blots were analysed by Densitometric scanning.
Data Presentation and Statistics For mortality studies, differences in experimental means were compared using the Fisher’s exact probability test. Experimental means were compared for other studies using one-way ANOVA and Tukey’s test for multiple comparisons. Differences were considered significant at P < 0.05. Each experiment was performed at least twice with comparable results.
Acknowledgements Supported by Veterans Administration Merit Review Grant (WGC and KMM). The authors thank Molly Redett for help with the manuscript.
infection / 535
REFERENCES 1. Bone RG (1991) The pathogenesis of sepsis. Ann Intern Med 115:457-467. 2. JanewayCA Jr, Bottomly K, Babich J, Conrad P, Conzen S, Jones B, Kaye J, Katz M, McVay L, Murphy DB, Tite .I (1984) Quantitative variation in Ia antigen expression plays a central role in immune regulation. Immunology Today 5:99-105. 3. Beutler B, Krochin N, Milsark IW, Luedke C, Cerami A (1986) Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 232:977-980. 4. Michie HR, Manogue KR, Spriggs DR, Rerhaug A, O’Dwyer S, Dinarello CA, Cerami A, Wolff SM, Wilmore DW (1988) Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 318:1481-1486. 5. Hesse DG, Tracey KJ, Fong Y, Manogue KR, Palladino MAJ, Cerami A, Shires GT, Lowry SF (1988) Cytokine appearance in human endotoxemia and primate bacteremia. Surg Gynecol Obstet 166:147-153. 6. Damas P, Reuter A, Gysen P, Demonty J, Lamy M, Franchimont P (1989) Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med 17:975978. 7. Creasey AA, Stevens P, Kenney J, Allison AC, Warren K, Catlett R, Hinshaw L, Taylor FB Jr (1991) Endotoxin and cytokine profile in plasma of baboons challenged with lethal and sublethal Escherichia coli. Circ Shock 33:84-91. 8. Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, M&ark IW, Hariri RJ, Fahey TJ III, Zentella A, Albert JD (1986) Shock and tissue injury induced by recombinant human cachectin. Science 234:470-474. 9. Natanson C, Eichenholz PW, Danner RL, Eichacker PQ, Hoffman WD, Kuo GC, Banks SM, MacVittie TJ, Parrillo JE (1989) Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J Exp Med 169:823-832. 10. Waage A, Espevik T (1988) Interleukin 1 potentiates the lethal effect of tumor necrosis factor alcachectin in mice. J Exp Med 167:1987-1992. 11. Okusawa S, Gelfand JA, Ikejima T, Connolly RJ, Dinarello CA (1988) Interleukin 1 induces a shock-like state in rabbits. J Clin Invest 81:1162-1172. 12. Beutler B, M&ark IW, Cerami AC (1985) Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229:869-871. 13. Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, Lowry SF, Cerami A (1987) Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330~662-664. 14. Ohlsson K, Bjork P, Bergenfeldt M, Hageman R, Thompson RC (1990) Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 348:550-552. 15. Alexander HR, Doherty GM, Buresch CM, Venzon DJ, Norton JA (1991) A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice. J Exp Med 173:1029-1032. 16. Wichterman KA, Baue AE, Chaudry IH (1980) Sepsis and septic shock: a review of laboratory models and a proposal. J Surg Res 29:189-201. 17. Dunn DL, Simmons RL (1983) The meaning of research in experimental peritonitis. Surgery 93:471-474. 18. Alexander HR, Doherty GM, Venzon DJ, Merino MJ, Fraker DL. Norton JA (1992) Recombinant interleukin-1 receotor antagonist (IL-lra): eff&tive therapy against gram-negative sepsis in rats. Surgery 112:188-194. 19. Hershman MJ, Polk HC, Pietsch JD, Shields RE, Wellhausen SR, Sonnenfeld G (1988) Modulation of infection following
536 I McMasters
et al.
trauma by interferon gamma treatment. Infect Immun 56:24122416. 20. Ulich T, Guo K, de1 Castillo J (1989) Endotoxin-induced cytokine gene expression in viva: expression of tumor necrosis factor mRNA in visceral organs under physiologic conditions and during endotoxemia. Am J Path01 134:11-14. 21. Bartlett JG, Onderdonk AB, Louie T, Kasper DL, Gorbach SL (1978) A review: lessons from an animal model of intra-abdominal sepsis. Arch Surg 113:853-857. 22. Parillo JE, Parker MM, Natanson C, Suffredini AF, Danner RL, Cunnion RE, Ognibene FP (1990) Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Int Med 113:227-242. 23. Evans GF, Snyder YM, Butler LD, Zuckerman SH (1989) Differential expression of interleukin-1 and tumor necrosis factor in murine septic shock models. Circ Shock 29:279-290. 24. Hannum CH, Wilcox CJ, Arend WP, Joslin FG, Dripps DJ, Heimdal PL, Armes LG, Sommer A, Eisenberg SP, Thompson RC, et al. (1990) Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 343:336-340. 25. Bagby GJ, Plessala KJ, Wilson LA, Thompson JJ, Nelson S (1991) Divergent efficacy of antibody to tumor necrosis factoralpha in intravascular and peritonitis models of sepsis. J Infect Dis 163:83-88. 26. Ayala A, Perrin MM, Kisala JM, Ertel W, Chaudry IH (1992) Polymicrobial sepsis selectively activates peritoneal but not alveolar macrophages to release inflammatory mediators (interleukins-1 and -6 and tumor necrosis factor). Circ Shock 36:191-199. 27. Ayala A, Kisala JM, Felt JA, Perrin MM, Chaudry IH (1992) Does endotoxin tolerance prevent the release of inflammatory monokines (interleukin 1, interleukin 6, or tumor necrosis factor) during sepsis? Arch Surg 127:191-197. 28. Hyde SR, McCallum RE (1992) Lipopolysaccharidetumor necrosis factor-glucocorticoid interactions during cecal ligation and puncture-induced sepsis in mature versus senescent mice. Infect Immun 60:976-982. 29. Ertel W, Morrison MH, Wang P, Ba ZF, Ayala A, Chaudry IH (1991) The complex pattern of cytokines in sepsis. Association between prostaglandins, cachectin and interleukins. Ann Surg 214:141-148. 30. Echtenacher B, Falk W, Mannel DN, Krammer PH (1990) Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J Immunol 145:37623766. 31. Hyde SR, Stith RD, McMallum RE (1990) Mortality and bacteriology of sepsis following cecal ligation and puncture in aged mice. Infect Immun 58:619-624. 32. Eskandari MK, Bolgos G, Miller C, Nguyen DT, Deforge LE, Remick DG (1992) Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture and endotoxemia. J Immunol148:2724-2730. 33. Hogan MM, Vogel SN (1988) Production of tumor necrosis factor by rIFN-gamma-primed C3WHeJ (LPSd) macrophages requires the presence of lipid A-associated proteins. J Immunol141:4196-4202. 34. Evans TJ, Strivens E, Carpenter A, Cohen J (1993) Differences in cytokine response and induction of nitric oxide synthase in endotoxin-resistant and endotoxin sensitive mice after intravenous gram negative infection. J Immunol 150:5033-5040.
CYTOKINE,
Vol. 6, No. 5 (September 1994: 530-536)
35. Kisala JM, Ayala A, Perrin MM, Stephan RN, Chaudry IH (1989) Lethality and altered macrophage (MI+) cytokine production following sepsis in endotoxin-tolerant mice [Abstract]. Circ Shock 27~304. 36. Baker CC, Niven-Fairchild T, Caragnano C, Kupper TS (1991) Outcome following femur fracture and subsequent cecal ligation and puncture in endotoxin-sensitive (C3HHeN) and endotoxin-resistant (C3HHeJ) mice. J Surg Res 50:170-174. 37. Baker CC, Niven-Fairchild T, Yamada A, Caragnano CL, Kupper TS (1991) Macrophage antigen presentation and interleukin 1 production after cecal ligation and puncture in C3WHeN and C3WHeJ mice. Arch Surg 126:253-258. 38. Fraker DL, Stovroff VC, Merino MJ, Norton JA (1988) Tolerance to tumor necrosis factor in rats and the relationship to endotoxin tolerance and toxicity. J Exp Med 168:95-105. 39. Sanchez-Cantu L, Rode HN, Christou NV (1989) Endotoxin tolerance is associated with reduced secretion of tumor necrosis factor. Arch Surg 124:1432-1436. 40. McMasters KM, Cheadle WG (1993) Regulation of macrophage TNFol, IL-lp, and Ia (I-Aa) mRNA expression during peritonitis is site dependent. J Surg Res 54:426-430. 41. Gallinaro RN, Naziri W, McMasters KM, Peyton JC, Cheatle WG (1994) Alteration of mononuclear cell immune associated antigen expression, interleukin-1 expression and antigen presentation during intra-abdominal infection. Shock. 1(2):130-134. 42. Cheadle WG, Hershman MJ, Wellhausen SR, Polk HC Jr (1991) HLA-DR antigen expression on peripheral blood monocytes correlates with surgical infection. Am J Surg 161:639-645. 43. Hershman MJ, Cheadle WG, Wellhausen SR, Davidson PF, Polk HC Jr (1990) Monocyte HLA-DR antigen expression characterizes clinical outcome in trauma patients. Br J Surg 77:204207. 44. Ertel W, Morrison MH, Ayala A, Perrin MM, Chaudry IH (1991) Anti-TNF monoclonal antibodies prevent haemorrhageinduced suppression of Kupffer cell antigen presentation and MHC class II expression. Immunology 74:290-297. 45. Bogdan C, Paik J, Vodovotz Y, Nathan C (1992) Contrasting mechanisms for macrophage cytokine release by transforming growth factor-p and interleukin-10. J Biol Chem 267:2330123308. 46. Baker CC, Chaudry IH, Gaines HO, Baue AE (1983) Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery 94:331-335. 47. Eskandari MK, Nguyen DT, Kunkel SL, Remick DG (1990) WEHI 164 subclone 13 assay for TNF: sensitivity, specificity, and reliability. Immunol Invest 19:69-79. 48. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159. 49. McMasters KM, Dickson LA, Shamy RV, Robischon K, Macdonald GJ, Moyle WR (1987) Rat cholesterol side-chain cleavage enzyme (P-450s~~): Use of a cDNA probe to study the hormonal regulation of P-450s~~ mRNA levels in ovarian granulosa cells. Gene 57:1-9. 50. Mendelssohn AR, Coleman JR (1992) Simple, rapid, reversible staining of nucleic acids immobilized on blots. Biotechniques 12:379-380.